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Abstract Two commercially available (EP, Z) and eight
new elastomeric composites (M1–M4, G1–G4, of thickness
&1 mm) containing mixtures of differing proportions of
heavy metal additives (Bi, W, Gd and Sb) have been
synthesised and examined as protective shields. The
intensity of the X-ray fluorescence radiation generated in
the typical elastomeric shields for CT, containing Bi and
other heavy metal additives influence on the practical
shielding properties. A method for assessing the radiation
shielding properties of elastomeric composites used in CT
examination procedures via X-ray spectrometry has been
proposed. To measure the radiation reduction ability of the
protective shields, the dose reduction factor (DRF) has
been determined. The lead equivalents for the examined
composites were within the ranges of 0.046–0.128 and
0.048–0.130 mm for 122.1 and 136.5 keV photons,
respectively. The proposed method, unlike to the common
approach, includes a dose contribution from the induced
X-ray fluorescence radiation of the heavy metal elements in
the protective shields. The results clearly indicate that
among the examined compositions, the highest values DRF
have been achieved with preparations containing Bi?W,
Bi?W?Gd and Bi?W?Sb mixtures with gradually
decreasing content of heavy metal additives in the fol-
lowing order: Bi, W, Gd and Sb. The respective values of
DRF obtained for the investigated composites were 21, 28
and 27 % dose reduction for a 1 mm thick shield and 39
and *50 % for a 2 mm thick layer (M1–M4).
Keywords X-ray florescence radiation  Dose reduction 
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Introduction
Computed tomography (CT) is valuable diagnostic tool
widely used in medical practices. Unfortunately, this
technique employs use of X-ray radiation resulting in rel-
atively high average effective doses from 2.4 mSv (head
examination) up to12.4 mSv (abdomen), usually exceeding
the average yearly doses from natural radiation of 2.4 mSv
[1]. Because of the powerful diagnostic possibilities with
CT and its clinical benefits, the use of CT has increased
explosively. For example, in the UK the use of CT has
grown in the last decade from accounting for 5–11 % of all
X-ray examinations to contributing up to 68 % of the
collective radiation doses from these sources [2]. Accord-
ing to the 2008 UNSCEAR report, 221 million CT exam-
inations are performed annually worldwide [1] with over
70 million in US alone in 2007 [4]. Moreover, a rapid
increase in paediatric CT has been observed, and because
children experience higher lifetime risks of fatal cancer
with each dose, one can expect an increased incidence in
some types of cancers attributable to CT among this group.
Despite many reports concerning the estimated cancer risk
from CT [3, 4], particularly from paediatric CT [5], the
problem of the dose reduction during CT scans has fre-
quently been underestimated [6]. This problem has been
additionally exacerbated by questioning the validity of the
linear, no-threshold model (LNT) for the relationship
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between an effective dose and increased cancer risks for
doses below 100 mSv [7, 8]. However, recent statistically
based epidemiological studies have proven a long-term link
between early childhood exposure for treatment of an
enlarged thymus (low-dose chest therapy) with an increase
in the relative risk of thyroid cancers in patients as com-
pared with their non-irradiated siblings [9]. Similarly, a
recent report concerning a large study of over 176,000
patients examined using CT in the National Health Service
centres in the UK demonstrated a positive association
between the radiation dose from CT scans and leukaemia
and brain tumours [10]. These findings confirmed the
necessity of developing new guidelines for CT scans to
reduce the doses of radiation received during these
examinations.
Designing new CT machines with reduced radiation
exposure with improvement in the CT techniques could
offer the ability to scan a chosen portion of the patient
using low-tube voltage protocols to substantially decrease
the doses [11].
An alternative method for dose reduction during CT
examination involves the use of plastic composites with
metal additives as a shield, particularly for radiosensitive
organs such as the eyes, thyroid glands, breast or gonads.
Such planar shields containing bismuth compounds are
currently used in radiology as they are commercially
available, and their practical use has recently been
reviewed [6]. However, the use of these shields is recom-
mended on the basis of dose reduction determined at
positions chosen using human-tissue-equivalent anthropo-
morphic phantoms [12, 13]. Application of heavy metal
additives is crucial due to their strong X-ray radiation
attenuation capabilities. However, one must keep in mind
that excitation of heavy metal atoms after absorption of the
incoming X-ray radiation may result in the generation of
secondary X-ray fluorescence radiation, which can escape
the shields and diminish their absorption effect. This effect
can cause the artifactually increase CT of numbers and
adversely affect the accuracy of CT numbers as well as
may also influence the image quality of the CT scan [14].
The other disadvantages, associated with the use of bis-
muth shields, especially when used with automatic expo-
sure control or tube current modulation. may lead to
unpredictable and potentially undesirable levels of dose.
Therefore, AAPM [15] and the Society of Cardiac CT
stated, that these shields are not recommended for CT
scanning [16]. However, such attitude is also discussed, as
the use of bismuth shields has unquestionable advantages,
especially in paediatric CT and some of these disadvan-
tages can be simply reduced [17, 18].
A simple way to improve the quality of CT scans with
simultaneous reducing of the doses with bismuth shield is
reducing of the dispersed by these shields radiation.
The principal idea of this study was to evaluate the
contribution of secondary excited X-ray fluorescence in Bi-
containing shields and to examine the possibility of
reducing its intensity via the simultaneous application of a
few metal additives to absorb X-ray photons of sequen-
tially higher excitation energies and shift them to lower
energy bands that are much easier to attenuate and do not
impact either the total dose absorbed during or the diag-
nostic quality of the CT scans.
Materials and methods
Eight different elastomeric shields containing Bi, W, Gd
and Sb in various proportions have been prepared to
determine the dose reduction factor (DRF) and their suit-
ability as shields in CT examination procedures.
The elastomeric samples have been prepared by pressing
natural rubber with typical vulcanisation additives and with
heavy metal admixtures in the form of the following oxi-
des: Bi2O3, WO3, Gd2O3 and Sb2O3. The final vulcanisa-
tion has been carried out at 160 C. The rubber compounds
with their formulations are provided in Table 1.





















M1 100 5 2 2 1 100 (111.5) – – –
M2 100 5 2 2 1 100 (111.5) 50 (63) – –
M3 100 5 2 2 1 100 (111.5) 50 (63) 25 (28.8) –
M4 100 5 2 2 1 100 (111.5) 50 (63) 25 (28.8) 10 (12)
G1 100 5 2 2 1 50 (55.75) – – –
G2 100 5 2 2 1 50 (55.75) 50 (63) – –
G3 100 5 2 2 1 50 (55.75) 50 (63) 50 (57.6) –
G4 100 5 2 2 1 50 (55.75) 50 (63) 50 (57.6) 50 (60)
phr parts per hundred rubber, nr natural rubber, MBT 2-Mercaptobenzothiazole
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Using this procedure, radiopaque composite elastomers
in the form of planar shields (25 9 25 cm2) with a thick-
ness of 1 mm were obtained as a starting material for the
protective shields [19]. The lead equivalent of these natural
rubber vulcanisates was 0.04–0.16 mm at 60 keV X-ray
radiation. The detailed compositions of the examined
shields are presented in Table 2, with samples of equal
metallic additive content (G1–G4) and with heavy metal
content that decreases progressively in the following order:
Bi, W, Gd and Sb (samples M1–M4). To study new
compositions, two commercially available shields have
been examined (SOMATEX CT Shields, samples EP and
Z, SOMATEX MEDICAL TECHNOLOGIES GMBH,
Germany).
For a radiation source that mimics the X-ray tube radi-
ation used in CT, a Co-57 closed isotopic source has been
applied providing c-rays of 122.1 (85.6 %) and 136.5
(10.7 %) keV., which closely approximates the typical
X-ray tube voltages applied in CT examinations. The
intensity of the excited X-ray photons was measured using
a c-ray spectrometry system with a high-resolution REGe
detector placed in a 5 cm thick lead shielding housing lined
with a 5 mm thick Zn plate cylinder. The resolution of the
detector was 0.9 keV for the 122 keV peak, and its relative
efficiency was 20 % for the 1.33 MeV peak. The data were
processed using a model S404 Inspector Spectroscopy
System (Canberra). Details of the detection system are
described elsewhere [20]. A schematic diagram of the
measuring system is shown in Fig. 1.
The Co-57 radionuclide was commercially available and
sealed in a polycarbonate case. To minimize the excitation
of the atoms from the lead shield and the possible inter-
ference of their radiation with the detector, the Co-57
source was also placed in a brass shielding housing. Two
brass collimators were used to diminish the influence of
scattered radiation. All spectra were recorded using Genie
2000 software from Canberra over 1,800 s. Each elasto-
meric shield sample had dimensions of approximately
4 9 4 cm2. The active area of the sample, visible to the
detector, was a 12.3 mm diameter surface (*120 mm2).










H C N O S Zn Sb Gd W Bi
M1 0.116 0.195 1.685 0.0543 0.4060 0.0008 0.0568 0.0125 0.0181 0.4515
M2 0.120 0.244 2.032 0.0423 0.3161 0.0006 0.0900 0.0097 0.0141 0.1756 0.3515
M3 0.105 0.230 2.190 0.0384 0.2871 0.0005 0.0939 0.0088 0.0128 0.0798 0.1595 0.3192
M4 0.108 0.236 2.185 0.0370 0.2765 0.0005 0.0965 0.0085 0.0123 0.0308 0.0768 0.1536 0.3075
G1 0.098 0.134 1.363 0.0725 0.5426 0.0010 0.0412 0.0167 0.0242 0.3017
G2 1.000 0.178 0.178 0.0525 0.3931 0.0007 0.0869 0.0121 0.0176 0.2185 0.2185
G3 0.093 0.176 1.894 0.0420 0.3140 0.0006 0.0961 0.0097 0.0140 0.1746 0.1746 0.1746
G4 0.095 0.174 1.836 0.0347 0.2597 0.0005 0.1079 0.0080 0.0116 0.1444 0.1444 0.1444 0.1444
EP 0.043 0.162 3.789 na na na na na na na ? ? ?
Z 0.103 0.172 1.668 na na na na na na na – – ?
‘‘?’’ or ‘‘-’’ presence detected or not detected
na data not available
Fig. 1 Schematic diagram of
the experimental setup
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The mass attenuation coefficients for the two main Co-57
emission lines (122.1 and 136.5 keV) were determined
according to the well-known exponential dependence:
I ¼ Ioelx ð1Þ
in which l is the mass attenuation coefficient in cm2/g and
x is the thickness in g/cm2. The given formula meets all
experimental conditions for a narrow monoenergetic pho-
ton beam; otherwise, a build-up factor (B) should be
introduced. In our experiments no build-up factor was
required for Eq. 1, as confirmed during the validation
experiments.
Because many naturally occurring radionuclides con-
tribute to the background radiation in the c- and X-ray
spectra within the energy range of interest (from 40 to
100 keV measured over 60,000 s), their contribution to the
natural detector background was subtracted from each
recorded spectrum. In addition, to achieve better accuracy
and more reliable results, a correction for the Compton
continuum was performed.
Calculations of the theoretical mass attenuation coeffi-
cients based on the sample compositions were performed
using XCom software available from the National Institute
of Standards and Technology (NIST) website [21, 22]. The
composition data for the human tissue (soft) used (H
10.20 %, C 14.30 %, N 3.40 %, O 70.80 %, Na 0.20 %,
P 0.30 %, S 0.30 %, Cl 0.20 %, K 0.30 %) to calculate the
mass attenuation coefficient and dose reduction factor were
also taken from the NIST database [23] and based on the
data included in the ICRU 44 report [24].
Results and discussion
The experimental procedure required validation of the
experimental setup and methods used for the calculations.
Simple measurements of the standardised Pb plates were
carried out for this validation during which the mass
attenuation coefficients were determined for the lead. The
results obtained were in good agreement with the theoret-
ical values, and the relative error of this method was
approximately 1 %. These values confirm that this meth-
odology can be successfully applied for mass attenuation
coefficient measurements in samples of novel composition
whose physical properties have not been fully determined.
The application of a Co-57 radiation source only allows for
experimental determination of mass attenuations coeffi-
cients for 122.1 and 136.5 keV photons. The measured
values of the attenuation coefficients for the Co-57 c lines
at 122.1 and 136.5 keV are in good agreement with the
values calculated taking into account the elastomer com-
positions. The relative deviation between the measured
values and those calculated does not exceed 15 %. The
lower energy mass attenuation coefficients used to calcu-
late the dose reduction factor were determined via calcu-
lations based on a particular sample composition. Table 3
presents the calculated and measured values for the l
coefficients and the equivalent lead values for the investi-
gated shields at both 122.1 and 136.5 keV.
The X-ray excitation spectra for the four rubber shields
containing Bi at practically the same concentration as the
other metal additives (0.30–0.35 mass fraction), Bi?W
(0.176 W mass), Bi?W?Gd (0.160 and 0.080 mass frac-
tions of W and Gd, respectively) and Bi?W?Gd?Sb
(0.154, 0.077 and 0.031 mass fractions of W, Gd and Sb,
respectively) are presented in Fig. 2. As shown in the fig-
ure, the X-ray photon intensities of 74.8, 77.1, 87.3 and
89.9 keV are observed for shield containing Bi only [25].
Additionally two energy lines that do not originate from Bi
excitation, 72.8 and 84.7 keV [25], are also observed and
should be assigned to Pb excitation, which is present
despite strong shielding by the detector housing. A natural
explanation for this fact is that lead housing excitation can
arise from cosmic radiation as confirmed during the
background measurements and the partial excitation of lead
via the Co-57 c photons, which although strong attenuated,
were not fully absorbed by the shield. After analysis of the
recorded spectra, one can conclude, that although much
weaker than the photon intensity of the Co-57 source, the
secondary X-ray fluorescence radiation arising from the
protective shield, should be considered as a dose contrib-
utor to the irradiated tissue. The dose aspect and the quality
of the registered CT scans suffer because of the additional
induced X-ray fluorescence radiation. The addition of a
second metallic component with a lower atomic number Z
could absorb the Bi X-ray fluorescence photons. For this
purpose, the addition of tungsten was examined. The
Table 3 Attenuation coefficients for 122.1 and 136.5 keV photons
and calculated lead equivalents values for investigated elastomeric
composites










M1 0.195 1.659 0.085 1.274 0.086
M2 0.244 1.768 0.128 1.352 0.130
M3 0.230 1.755 0.120 1.340 0.121
M4 0.236 1.724 0.121 1.316 0.122
G1 0.134 1.164 0.046 0.905 0.048
G2 0.178 1.435 0.076 1.102 0.077
G3 0.176 1.474 0.077 1.127 0.078
G4 0.174 1.375 0.071 1.052 0.072
EP 0.162 1.606 0.068 1.206 0.068
Z 0.172 1.555 0.080 1.174 0.079
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presence of tungsten in the elastomeric bismuth shield
leads to a substantial reduction of the all Bi line intensities
as evidenced by the presented spectra. However, as a result,
four new W photon emission lines are generated in the
lower portion of the spectrum with energies characteristic
of W excitation, 58.0, 59.3, 67.2 and 69.1 keV (M2 com-
posite) [25]. These photons can be absorbed by the addition
of another additive with a lower Z and X-ray excitation
levels slightly below the energy of tungsten-emitted pho-
tons, for example, gadolinium. The addition of this element
results in a reduction in the W emission intensity; however,
two group of photons of 42.7 and 48.7 keV energy, cor-
responding to gadolinium emissions (M3) [25], are gener-
ated with lower intensities. These photons can be absorbed
more easily than those emitted by Bi or W with energies of
approximately 60–90 keV. A similar effect of reduced Gd
X-ray emission photons could be expected after the addi-
tion of Sb (composite M4); however, as shown in Fig. 2,
this result is not clear. From the other side, the low-energy
Gd X-ray emission is not as important as the Bi and W
fluorescence radiation emission together with the
120–140 keV Co-57 c radiation. More detailed observa-
tions can be seen in Figs. 3 and 4 in which the data col-
lected for particular photon emission intensities for Bi, W
and Gd are presented for each composite. Given that the
lower limit of photon energy visible to our REGe detector
is *40 keV, no c-ray or X-ray photons below this value
were observed, which is of concern to the Sb emission.
This fact renders the measurement of photon emissions
below 40 keV for Bi, W and Gd impossible. However, due
to strong absorption of photons from this energy range and
the reduced fluorescence yields for the excitation from
shells other than K, the contributions photons at energies
below 40 keV could, in practice, be neglected from the
total doses outside the shields.
The intensity of the X-ray fluorescence radiation gener-
ated by the interaction of the photons with matter depends
on the many factors [26]. This interaction is governed by the
following variables: interacting photon flux (Rc), the prob-
ability of the photoelectric absorption (s), the photon
emission probability or fluorescence yield (x) for a partic-
ular absorption process (K, L1, L2, L3, etc.), the branching
ratio for a specific transition of electron de-excitation pro-
cess (KL2, KL3, KM2, etc.), the concentration of the ele-
ment being excited (cMe) and finally, the thickness of the
irradiated material (x). Additionally, X-ray excitation radi-
ation will be absorbed within the material (lf). In general,
when more than one group of photons can interact with the
irradiated material, the intensity Rf (photons/s) of the
characteristic X-rays generated at distance dx within the






dx  Rflfdx ð2Þ
In our experiments, the Co-57 source emits two c
photons at slightly distinct energies. Thus, Eq. 2 will be
transformed to Eq. 3.
dRF ¼ xBcMe R0c1el1xs1 þ R0c2el2xs2
 
dx  Rflfdx ð3Þ
Fig. 2 Influence of metallic
additives (xMe) on X-ray
emission spectra of the
elastomeric shields
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in which R0c1 and R
0
c2 equal the initial intensities of the
excitation photons from the Co-57 source at 122.1 and
136.5 keV, respectively; s1 and s2 represent the photoelec-
tric absorption coefficients for a given photon energy and
metal additive; l1, l2 and lf are the mass attenuation coef-
ficients for 122.1, 136.5 keV and the secondary fluorescence
radiation, respectively, in cm2/g; x and B represent the K
fluorescence yield and branching ratio for the transition of a
specific X-ray emission photon energy; cMe is the concen-
tration of the metal additive in the bulk material; and
dx represents the shield surface density increment in g/cm2.
After integrating Eq. 3 for the initial condition of Rf = 0
for x = 0, one can obtain the following solution for the
intensity Rf of any particular characteristic X-ray photon









el2x  elf xð Þ
ð4Þ
Under these experimental conditions, the observed
intensity in the fluorescence radiation is primarily dependent
Fig. 3 (a) Influence of the shield thickness on the intensities of the two different Bi concentrations (89.9 and 77.1 keV lines); (b) Effect of the
shield thickness on the intensity of two W emission lines (for 58.0 and 59.3 keV photons) for composites containing Gd
Fig. 4 Comparison of the main X-ray emission lines intensities of Bi (a), and W (b) for chosen composite shields
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on the first segment of this two-component relationship, while
the second component only partially contributes to the total
X-ray photon intensity. This conclusion can be easily justified
by the contribution of the 136.5 keV radiation flux as
compared with that of the main line, which is 122.1 keV
(10.7 % emission probability towards 85.6 %). The
attenuation factor for the higher energy photons is slightly
reduced in the given material, which in fact increases the
second component, and does not essentially affect this
proportion. This relationship can lead to a saturation curve
or a curve with a maximum of fluorescent radiation intensity
whose position depends on the physical parameters of the
system, particularly the attenuation coefficients. Obviously,
these attenuation coefficients,l, are strongly dependent on the
effective atomic number of the shield [27], as is the function of
the heavy metal content. In contrast, an increase in the
concentration of heavy metals results in a higher probability of
photon-Bi atomic interactions. The influence of the rubber
shield surface density x on the intensity Rf on the 89.9 and
77.1 keV characteristic Bi lines is shown for the two rubber
composites; those containing the different Bi concentrations
M1 and G1 are presented in Fig. 3a.
Figure 3a clearly shows that the saturation intensity of
these two Bi lines is observed for a thickness of approxi-
mately 0.7–0.8 g/cm2. Increasing the Bi concentration only
slightly influences the 89.9 keV line intensity, whereas the
77.1 keV line intensity is affected to a higher extent. This
line (77.1 keV) may cause undesirable effects on the
quality of the CT scans, thus its intensity should be reduced
not only by increasing the thickness of the shields but also
by adding another metal capable of absorbing these pho-
tons in the range of 72–79 keV. Tungsten, for example,
exhibits a high attenuation coefficient in the range of
69–80 keV [21, 22]. The addition of tungsten—for which
the K absorption edge (69.5 keV) [25] is just below the Bi
emission energies—is especially beneficial due to the
corresponding energy values for Bi emission and W
absorption. However, when these two metals are the only
additives, the undesirable effects of the tungsten emissions
can be observed in the 58–60 keV energy range, which is
still important to the CT protocols. As previously men-
tioned, the intensities can be further reduced by the addi-
tion of another metallic compound with a lower atomic
number, Z, for example, Gd. In such systems, the reduction
in photon emission intensity for all spectral energies from
58 to 90 keV is clearly observed and presented in Fig. 2. In
the presence of the Gd, photons emitted from the W atoms
are absorbed more efficiently by shields that have a total
thickness greater than 0.5 g/cm2. The emission saturation
maxima of these W photons are shifted toward lower
thickness values comparing with those for Bi (Fig. 3b).
The question remains as to the measurable effects of the
addition of heavy metals in the order of Bi, W, Gd and Sb,
and how these additives and their concentrations influence
the dose absorbed in the tissue. A suitable parameter for
describing the protective shield should provide information
regarding the ability of this material to reduce the dose. In a
simple approach, the dose rate can be calculated as the sum
of the products of the radiation flux (I, in 1/cm2 s), the mass
attenuation coefficient for the material being irradiated
(tissue, lTS in cm
2/g) and the energy of the absorbed
photon(s) (E in keV) with k as an unit correction factor.





Using the above formula, a dose rate can be estimated
for cases both with and without application of an
elastomeric shielding material.
The dose reduction factor (DRF) coefficient can be used
to assess the shielding properties of the elastomeric com-
posites. The DRF coefficient can be defined simply as a
ratio of the dose absorbed after the application of an
elastomeric shield (D) to that without the application of a
Table 4 Calculated dose
reduction factors (DRF) for
examined composites
a X-ray fluorescence radiation
of Bi, W and Gd involved
b Only for 122.1 and 136.5 keV
Co57 photons
Composite Additive(s) d (g/cm2)
(1 layer)
DRFa DRFb d (g/cm2)
(2 layers)
DRFa DRFb
M1 Bi 0.195 0.79 0.78 0.391 0.61 0.60
M2 Bi ? W 0.244 0.72 0.70 0.488 0.50 0.49
M3 Bi ? W ? Gd 0.230 0.73 0.72 0.460 0.51 0.50
M4 Bi ? W ? Gd ? Sb 0.236 0.73 0.72 0.472 0.52 0.51
G1 Bi 0.134 0.89 0.88 0.267 0.78 0.77
G2 Bi ? W 0.178 0.82 0.81 0.355 0.67 0.66
G3 Bi ? W ? Gd 0.176 0.82 0.81 0.352 0.66 0.65
G4 Bi ? W ? Gd ? Sb 0.174 0.80 0.80 0.349 0.65 0.64
EP Bi ? W ? Gd 0.162 0.79 0.78 0.322 0.62 0.61
Z Bi 0.172 0.78 0.77 0.344 0.61 0.60
J Radioanal Nucl Chem (2013) 298:1913–1921 1919
123











The values of the DRF coefficients for the investigated
composites, calculated according to Eq. 6, are listed in
Table 4. The DRF coefficients for Co-57 radiation are
presented with the DRF values calculated including both
Co-57 and X-ray fluorescence radiation for comparison. As
shown, these values are similar regardless of the method of
calculation, with or without considering any X-ray fluoresce
radiation induced within the shield material. Differences
in the dose reduction factor values are at most 1–2 % for a
1 mm thick layer. Nevertheless, our results clearly indicate
that X-ray fluorescence should be taken into account when
estimating the total dose reduction for a particular shielding
material containing heavy metal additives.
Conclusions
Common methods used for determining the shielding
properties of materials used in CT examinations require the
application of devices such as TLD dosimeters or ionisa-
tion chambers and body phantoms to simulate the condi-
tions of human-body CT examinations. Our method is
based solely on simple X-ray spectrometric measurements
including the fluorescence radiation generated in the
shields. Results of our investigations revealed, that fluo-
rescence radiation from the metal additives present in the
elastomeric shields have slight contribution to the dose
reduction during CT examination. However, the fluores-
cence radiation in the range of 58–90 keV emitted from
two frequently used metal additives, Bi and W, can influ-
ence the quality of CT scans. Therefore, the addition of the
third metal component, Gd, can substantially shift this
radiation to the range of 40 keV, which is less critical for
this diagnostic procedure. Another option involves the
addition of a fourth metal additive, Sb, to the elastomer
shield to decrease the dose. Among the shielding materials
examined, the elastomers most able to reduce the radiation
dose are those that contain at least three heavy metal
additives in concentrations that gradually decrease in the
order of Bi, W, Gd and Sb (composites M2–M4).
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